Cancer diagnostics and genomic testing platform under Abbott ownership
Exact Sciences, now part of Abbott, operates a precision oncology and genomic testing business focused on cancer screening and diagnostics. The tech stack reveals a hybrid clinical-software infrastructure: Epic Systems and EHR systems for patient workflows, Salesforce and Veeva CRM for go-to-market, but also modern data engineering (Databricks, Python, Kubernetes, CI/CD) and observability tooling (Arize, Label Studio, MLflow). Active adoption of RISE with SAP and SAP Business AI signals a shift toward AI-augmented enterprise processes across diagnostics and supply-chain operations. Sales hiring (60 roles) and healthcare specialists (31 roles) dominate current velocity, suggesting market expansion and clinical integration work post-acquisition.
Notable leadership hires: Medical Affairs Director, HEOR Director, Training Director
Exact Sciences is a publicly traded diagnostics company now integrated into Abbott, a global healthcare firm with 122,000 employees serving 160+ countries. The company develops genomic and precision oncology testing platforms, including branded assays like Cologuard, to enable cancer screening and diagnosis. Operations span product development, clinical validation, digital health strategy, and go-to-market execution. Active projects show focus on digital health market positioning, product utilization optimization, and regional business planning. The organization manages complex regulatory and compliance requirements intrinsic to diagnostic and genetic testing at clinical scale.
Core diagnostics and EHR integration (Epic, LIMS, Tecan instrumentation), analytics (Tableau, Databricks, SAS), cloud (AWS, Azure, GCP), enterprise software (SAP suite, Salesforce, Veeva CRM), and ML operations (MLflow, Arize, Label Studio) for assay and bias monitoring.
Digital health market expansion, Cologuard product utilization planning, diagnostic assay development, observability and telemetry infrastructure, patient access improvement, and regional business planning post-Abbott integration.
Exact Sciences's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.